- Home
- LPTH vs ABOS Comparison
LPTH vs ABOS Comparison
Compare LPTH & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- ABOS
- Stock Information
- Founded
- LPTH 1985
- ABOS 1996
- Country
- LPTH United States
- ABOS United States
- Employees
- LPTH N/A
- ABOS N/A
- Industry
- LPTH Semiconductors
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- ABOS Health Care
- Exchange
- LPTH Nasdaq
- ABOS Nasdaq
- Market Cap
- LPTH 81.1M
- ABOS 76.9M
- IPO Year
- LPTH 1996
- ABOS 2021
- Fundamental
- Price
- LPTH $1.90
- ABOS $0.99
- Analyst Decision
- LPTH Strong Buy
- ABOS Strong Buy
- Analyst Count
- LPTH 3
- ABOS 3
- Target Price
- LPTH $4.67
- ABOS $7.33
- AVG Volume (30 Days)
- LPTH 107.1K
- ABOS 215.3K
- Earning Date
- LPTH 05-08-2025
- ABOS 03-27-2025
- Dividend Yield
- LPTH N/A
- ABOS N/A
- EPS Growth
- LPTH N/A
- ABOS N/A
- EPS
- LPTH N/A
- ABOS N/A
- Revenue
- LPTH $32,158,517.00
- ABOS N/A
- Revenue This Year
- LPTH $16.90
- ABOS N/A
- Revenue Next Year
- LPTH $52.77
- ABOS N/A
- P/E Ratio
- LPTH N/A
- ABOS N/A
- Revenue Growth
- LPTH N/A
- ABOS N/A
- 52 Week Low
- LPTH $1.04
- ABOS $0.98
- 52 Week High
- LPTH $4.42
- ABOS $4.06
- Technical
- Relative Strength Index (RSI)
- LPTH 35.13
- ABOS 29.79
- Support Level
- LPTH $2.03
- ABOS $1.14
- Resistance Level
- LPTH $2.24
- ABOS $1.28
- Average True Range (ATR)
- LPTH 0.17
- ABOS 0.10
- MACD
- LPTH 0.01
- ABOS -0.01
- Stochastic Oscillator
- LPTH 19.35
- ABOS 1.54
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.